Neuroimaging predictors of structural epilepsy in the COVID-19 catamnesis
https://doi.org/10.17749/2077-8333/epi.par.con.2021.092
Abstract
Respiratory system pathology is the most common clinical disorder associated with COVID-19. However, there are also lesions of the immune, cardiovascular, genitourinary, endocrine systems, and digestive tract. In addition, there are numerous reports on infection-related neurological manifestations, which can be divided into 3 groups: central nervous system manifestations (headache and dizziness, stroke, encephalopathy, encephalitis, acute myelitis), lesions of the peripheral nervous system (anosmia, Guillain–Barre syndrome), secondary lesions in the skeletal muscles. Brain damage that occurs during novel coronavirus infection and determines some of the above-mentioned manifestations often account for the development of structural epilepsies. Only a few scarce review articles on neuroimaging features in patients with COVID-19 have been found in Russian research publications.
The objective of the review was to collect, analyze and summarize the results of brain magnetic resonance imaging (MRI), currently accumulated worldwide in patients with COVID-19. We present the most common diagnoses based on brain MRI in patients with COVID-19 established by foreign researchers from March 2020 to March 2021, as well as initial attempts to interpret the pathophysiological mechanisms of the changes observed in the brain substance.
About the Authors
N. E. Maslov
Almazov National Medical Research Center
Russian Federation
Russian Federation
Nikita E. Maslov – Resident, Chair of Radiology and Medical Imaging
2 Akkuratov Str., Saint Petersburg
RSCI SPIN-code: 1422-8694
N. V. Yuryeva
Smolensk State Medical University
Russian Federation
Russian Federation
Natalia V. Yuryeva – MD, PhD, Associate Professor, Chair of Neurology and Neurosurgery
28 Krupskaya Str., Smolensk 214019
RSCI SPIN-code: 4193-3595
E. I. Khamtsova
Smolensk State Medical University
Russian Federation
Russian Federation
Elena I. Khamtsova – MD, PhD, Associate Professor, Chair of Neurology and Neurosurgery
28 Krupskaya Str., Smolensk 214019
RSCI SPIN-code: 4091-5210
A. A. Litvinova
Smolensk State Medical University
Russian Federation
Russian Federation
Aleksandra A. Litvinova – 4th-year Student, Faculty of General Medicine
28 Krupskaya Str., Smolensk 214019
RSCI SPIN-code: 2234-7591
References
1. Nikbakht F., Mohammadkhanizadeh A., Mohammadi E. How does the COVID-19 cause seizure and epilepsy in patients? The potential mechanisms. Mult Scler Relat Disord. 2020; 46: 102535. https://doi.org/10.1016/j.msard.2020.102535.
2. Vezzani A., Fujinami R.S., White H.S., et al. Infections, inflammation and epilepsy. Acta Neuropathol. 2016; 131 (2): 211–34. https://doi.org/10.1007/s00401-015-1481-5.
3. Mahammedi A., Saba L., Vagal A., et al. Imaging of neurologic disease in hospitalized patients with COVID-19: an Italian multicenter retrospective observational study. Radiology. 2020; 297 (2): E270–3. https://doi.org/10.1148/radiol.2020201933.
4. Mao L., Jin H., Wang M., et al. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol. 2020; 77 (6): 683–90. https://doi.org/10.1001/ jamaneurol.2020.1127.
5. Asadi-Pooya A.A. Seizures associated with coronavirus infections. Seizure. 2020; 79: 49–52. https://doi.org/10.1016/j.seizure.2020.05.005.
6. Asadi-Pooya A.A., Simani L., Shahisavandi M., Barzegar Z. COVID-19, de novo seizures, and epilepsy: a systematic review. Neurol Sci. 2021; 42 (2): 415–31. https://doi.org/10.1007/s10072-020-04932-2.
7. Liotta E.M., Batra A., Clark J.R., et al. Frequent neurologic manifestations and encephalopathy-associated morbidity in COVID-19 patients. Ann Clin Transl Neurol. 2020; 7 (11): 2221–30. https://doi.org/10.1002/acn3.51210.
8. Radmanesh A., Raz E., Zan E., et al. Brain imaging use and findings in COVID-19: a single academic center experience in the epicenter of disease in the United States. AJNR Am J Neuroradiol. 2020; 41 (7): 1179–83. https://doi.org/10.3174/ajnr.A6610.
9. Karlov V.А. Epilepsy in children and adult women and men. A guide for doctors. 2nd ed. Мoscow: BINOM; 2019: 896 p
10. Kubota T., Gajera P.K., Kuroda N. Meta-analysis of EEG findings in patients with COVID-19. Epilepsy Behav. 2021; 115: 107682. https://doi.org/10.1016/j.yebeh.2020.107682.
11. Roberto K.T., Espiritu A.I., Fernandez M.L., Gutierrez J.C. Electroencephalographic findings in COVID-19 patients: a systematic review. Seizure. 2020; 82: 17–22. https://doi.org/10.1016/j.seizure.2020.09.007.
12. Rodrigo-Armenteros P., Uterga-Valiente J.M., Zabala-Del-Arco J., et al. Non-convulsive status epilepticus in a patient with COVID-19 infection. Clin Neurophysiol. 2020; 131 (11): 2588–90. https://doi.org/10.1016/j.clinph.2020.08.005.
13. DeKosky S.T., Kochanek P.M., Valadka A.B., et al. Blood biomarkers for detection of brain injury in COVID-19 patients. J Neurotrauma. 2021; 38 (1): 1–43. https://doi.org/10.1089/neu.2020.7332.
14. Whelan C.D., Altmann A., Botía J.A., et al. Structural brain abnormalities in the common epilepsies assessed in a worldwide ENIGMA study. Brain. 2018; 141 (2): 391–408. https://doi.org/10.1093/brain/awx341.
15. Duncan J.S., Winston G.P., Koepp M.J., Ourselin S. Brain imaging in the assessment for epilepsy surgery. Lancet Neurol. 2016; 15 (4): 420–33. https://doi.org/10.1016/S1474-4422(15)00383-X.
16. Belopasov V.V., Yachou Y., Samoilova E.M., Baklaushev V.P. The nervous system damage in COVID-19. Journal of Clinical Practice. 2020; 11 (2): 60–80 (in Russ.). https://doi.org/10.17816/clinpract34851.
17. Kremer S., Lersy F., de Sèze J., et al. Brain MRI findings in severe COVID-19: a retrospective observational study. Radiology. 2020; 297 (2): E242–51. https://doi.org/10.1148/radiol.2020202222.
18. Moriguchi T., Harii N., Goto J., et al. A first case of meningitis/ encephalitis associated with SARS-Coronavirus-2. Int J Infect Dis. 2020; 94: 55–8. https://doi.org/10.1016/j.ijid.2020.03.062.
19. Budhram A., Leung A., Nicolle M.W., Burneo J.G. Diagnosing autoimmune limbic encephalitis. CMAJ. 2019; 191 (19): E529–34. https://doi.org/10.1503/cmaj.181548.
20. Parsons T., Banks S., Bae C., et al. COVID-19-associated acute disseminated encephalomyelitis (ADEM). J Neurol. 2020; 267 (10): 2799–802. https://doi.org/10.1007/s00415-020-09951-9.
21. Pohl D., Alper G., Van Haren K., et al. Acute disseminated encephalomyelitis: updates on an inflammatory CNS syndrome. Neurology. 2016; 87 (9 Suppl. 2): S38–45. https://doi.org/10.1212/WNL.0000000000002825.
22. Nabi S., Badshah M., Ahmed S., Nomani A.Z. Weston–Hurst syndrome: a rare fulminant form of acute disseminated encephalomyelitis (ADEM). BMJ Case Rep. 2016; 2016: bcr2016217215. https://doi.org/10.1136/bcr-2016-217215.
23. Needham E.J., Chou S.H., Coles A.J., Menon D.K. Neurological implications of COVID-19 infections. Neurocrit Care. 2020; 32 (3): 667–71. https://doi.org/10.1007/s12028-020-00978-4.
24. Reichard R.R., Kashani K.B., Boire N.A., et al. Neuropathology of COVID-19: a spectrum of vascular and acute disseminated encephalomyelitis (ADEM)-like pathology. Acta Neuropathol. 2020; 140 (1): 1–6. https://doi.org/10.1007/s00401-020-02166-2.
25. Radmanesh A., Derman A., Lui Y.W., et al. COVID-19-associated diffuse leukoencephalopathy and microhemorrhages. Radiology. 2020; 297 (1): E223–7. https://doi.org/10.1148/radiol.2020202040.
26. Radmanesh F., Rodriguez-Pla A., Pincus M.D., Burns J.D. Severe cerebral involvement in adult-onset hemophagocytic lymphohistiocytosis. J Clin Neurosci. 2020; 76: 236–7. https://doi.org/10.1016/j.jocn.2020.04.054.
27. Katyal N., Narula N., George P., et al. Delayed post-hypoxic leukoencephalopathy: a case series and review of the literature. Cureus. 2018; 10 (4): e2481. https://doi.org/10.7759/cureus.2481.
28. Kandemirli S.G., Dogan L., Sarikaya Z.T., et al. Brain MRI findings in patients in the intensive care unit with COVID-19 infection. Radiology. 2020; 297 (1): E232–5. https://doi.org/10.1148/radiol.2020201697.
29. Kishfy L., Casasola M., Banankhah P., et al. Posterior reversible encephalopathy syndrome (PRES) as a neurological association in severe COVID-19. J Neurol Sci. 2020; 414: 116943. https://doi.org/10.1016/j.jns.2020.116943.
30. Gulko E., Oleksk M.L., Gomes W., et al. MRI brain findings in 126 patients with COVID-19: initial observations from a descriptive literature review. AJNR Am J Neuroradiol. 2020; 41 (12): 2199–203. https://doi.org/10.3174/ajnr.A6805.
31. Choi Y., Lee M.K. Neuroimaging findings of brain MRI and CT in patients with COVID-19: a systematic review and meta-analysis. Eur J Radiol. 2020; 133: 109393. https://doi.org/10.1016/j.ejrad.2020.109393.
32. Nepal G., Rehrig J.H., Shrestha G.S., et al. Neurological manifestations of COVID-19: a systematic review. Crit Care. 2020; 24 (1): 421. https://doi.org/10.1186/s13054-020-03121-z.
33. Maas M.B. Critical medical illness and the nervous system. Continuum (Minneap Minn). 2020; 26 (3): 675–94. https://doi.org/10.1212/CON.0000000000000869.
34. Radmanesh A., Derman A., Lui Y.W., et al. COVID-19-associated diffuse leukoencephalopathy and microhemorrhages. Radiology. 2020; 297 (1): E223–7. https://doi.org/10.1148/radiol.2020202040.
35. Coolen T., Lolli V., Sadeghi N., et al. Early postmortem brain MRI findings in COVID-19 non-survivors. Neurology. 2020; 95 (14): e2016–27. https://doi.org/10.1212/WNL.0000000000010116.
36. Chougar L., Shor N., Weiss N., et al. Retrospective observational study of brain MRI findings in patients with acute SARS-CoV-2 infection and neurologic manifestations. Radiology. 2020; 297 (3): E313–23. https://doi.org/10.1148/radiol.2020202422.
37. D’Amore F., Vinacci G., Agosti E., et al. Pressing issues in COVID-19: probable cause to seize SARS-CoV-2 for its preferential involvement of posterior circulation manifesting as severe posterior reversible encephalopathy syndrome and posterior strokes. AJNR Am J Neuroradiol. 2020; 41 (10): 1800–3. https://doi.org/10.3174/ajnr.A6679.
38. Li Z., Liu T., Yang N., et al. Neurological manifestations of patients with COVID-19: potential routes of SARS-CoV-2 neuroinvasion from the periphery to the brain. Front Med. 2020; 14 (5): 533–41. https://doi.org/10.1007/s11684-020-0786-5.
39. Yavarpour-Bali H., Ghasemi-Kasman M. Update on neurological manifestations of COVID-19. Life Sci. 2020; 257: 118063. https://doi.org/10.1016/j.lfs.2020.118063.
Review
For citations:
Maslov N.E., Yuryeva N.V., Khamtsova E.I., Litvinova A.A. Neuroimaging predictors of structural epilepsy in the COVID-19 catamnesis. Epilepsy and paroxysmal conditions. 2021;13(3):274-285. (In Russ.) https://doi.org/10.17749/2077-8333/epi.par.con.2021.092
Views: 415
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Email this article 
